Please login to the form below

Not currently logged in
Email:
Password:

Antares appoints David Bergstrom as SVP

Second major appointment in one month

Antares Pharma has appointed Dr David Bergstrom as senior VP of pharmaceutical development.

Dr Bergstrom joins from Advantar Laboratories where he serves as executive VP and chief operating officer.

His previous roles included spells as chief operating office of NoveDel Pharmaceuticals and general manager of pharmaceutical development at Cardinal Health.

He is the second senior VP to join Antares this month after the appointment of former Pfizer VP Dr Bruce Freundlich as senior VP, medical.

The appointments come as the company looks to expand its business after the commercialisation of Otrexup (methotrexate) for arthritis and the advance in development of testosterone replacement therapy Vibex QS T.

Dr Paul Wotton, CEO of Antares, said: "David has a proven track record as a leader of product development teams and has worked on multiple FDA approved products including 505B2 drug/device combination programmes. His broad product development expertise will help drive our pipeline initiative."

20th November 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics